|Title:||UTILIZATION OF GON-4-ENE THERAPY IN TREATMENT OF FEMALES AND IN GROWTH STIMULATION|
|Abstract:||Methods of using certain 13-ethyl-gon-4-enes are described, namely 13.beta.,17.alpha.-diethyl-17.beta.-hydroxygon-4-en-3-one, and the decanoate ester of 13.beta.-ethyl-17.beta.-hydroxygon-4-en-3-one for growth stimulation in mammals; and 13.beta.-ethyl-17.alpha.-ethynyl-17.beta.-hydroxygon-4-en-3-one, to treat dysfunctions of the female reproductive system in mammals, to control cyclic regularity, and to prevent conception in female mammals.|
|Inventor(s):||Hughes; Gordon Alan (Haverford, PA), Smith; Herchel (Wayne, PA)|
|Assignee:||SAID Smith, by said Hughes (N/A)|
Patent Claim Types:|
see list of patent claims
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.